Ropivacaine-loaded, hydroxypropyl chitin thermo-sensitive hydrogel combined with hyaluronan: an injectable, sustained-release system for providing long-lasting local anesthesia in rats

• Published in: Regional anesthesia and pain medicine Vol. 47; no. 4; pp. 234 - 241
• Main Authors: Qiao, Qianqian, Fu, Xiangyun, Huang, Rui, Lei, Shaoqing, Leng, Yan, Liu, Zhigang, Xia, Zhongyuan, Jiang, Xulin
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group Ltd 01.04.2022; BMJ Publishing Group LTD
• Subjects: Amides - toxicity; analgesia; Analgesics - therapeutic use; anesthesia; Anesthesia, Local; Anesthetics, Local; animal experimentation; Animals; Chitin; Cytotoxicity; Delayed-Action Preparations; Drug delivery systems; Humans; Hyaluronic acid; Hyaluronic Acid - toxicity; Hydrogels; Hydrogels - pharmacology; Hydrogels - therapeutic use; local; Local anesthesia; nerve block; Normal distribution; Original research; Pain; pain management; Rats; Regional anesthesia; Rodents; Ropivacaine; Ultrasonic imaging; Variance analysis; animal experimentation; pain management; nerve block; local; analgesia; anesthesia
• ISSN: 1098-7339; 1532-8651; 1532-8651
• DOI: 10.1136/rapm-2021-102726

Background and objectiveRopivacaine hydrochloride is a commonly used local anesthetic in clinics. However, local injection or continuous infusion of ropivacaine has been associated with several disadvantages. Accordingly, it is important to develop a new controlled release system for local administration of ropivacaine to achieve a prolong anesthetic effect, improve efficacy, and minimize the side effects.MethodsWe developed injectable hydroxypropyl chitin thermo-sensitive hydrogel (HPCH) combined with hyaluronan (HA), which was used to synthesize a ropivacaine (R)-loaded controlled release system. We then conducted drug release test and cytotoxicity assay in vitro. Importantly, we examined the analgesic effects and biocompatibility of this system in vivo by injecting different concentrations of R-HPCH-HA (7.5, 15, 22.5 mg/mL), ropivacaine hydrochloride (RHCL, 7.5 mg/mL), or saline (all in 0.5 mL) near the sciatic nerve in rats.ResultsR-HPCH-HA induced concentration-dependent thermal-sensory blockade and motor blockade in vivo. In hot plate test, R-HPCH-HA (22.5 mg/mL) induced a significant longer thermal-sensory blockade (17.7±0.7 hours), as compared with RHCL (7.5 mg/mL, 5.7±0.8 hours, n=6/group, p<0.05). It also produced a more prolonged motor blockade (6.8±0.8 hours) than RHCL (3.5±0.8 hours, p<0.05). R-HPCH-HA caused less cytotoxicity than RHCL, as indicated by the higher cell viability in vitro (n=8/group).ConclusionOur findings in a sciatic nerve block model demonstrated that the injectable, ropivacaine-loaded controlled release system effectively prolonged the local analgesic effect in rats without notable side effects.